All 260 IBBQ (INVESCO NASDAQ BIOTECHNOLOGY ETF) Holdings
There are 260 IBBQ holdings. Top 10 companies weight: 40.98%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (260 stocks) | +19.22% | 19.98 | 14.72 | 0.43 | +42.13% | +7.97% | 0.80 | ||||||||||
51 | CGON | Cg Oncology Inc | 0.42% | $55.53 | $5.35B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +62.60% | $90 | 0.00% | 1.46 |
52 | SRRK | Scholar Rock Holding Corp | 0.42% | $44.68 | $6.03B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +32.05% | $59 | +10.50% | 0.67 |
53 | CRSP | Crispr Therapeutics Ag | 0.40% | $52.02 | $5.16B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | N/A | N/A | N/A | -13.88% | N/A |
54 | LGND | Ligand Pharmaceuticals Inc | 0.38% | $232.76 | $4.72B | Biotechnology | Healthcare | +26.59% | 30.19 | 25.77 | 1.53 | N/A | N/A | 80 | +19.26% | $278 | +15.54% | 1.02 |
55 | INDV | N/A | 0.38% | $33.71 | $4.60B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 23.54 | 11.38 | N/A | N/A | N/A | 79 | +52.77% | $52 | +25.39% | 0.72 |
56 | CNTA | Centessa Pharmaceuticals Plc Adr | 0.38% | $39.90 | $6.15B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +12.58% | N/A |
57 | APGE | Apogee Therapeutics Inc | 0.37% | $78.71 | $5.82B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +50.51% | $118 | 0.00% | 1.30 |
58 | XENE | Xenon Pharmaceuticals Inc | 0.36% | $52.30 | $5.21B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +51.63% | $79 | +23.02% | 0.95 |
59 | CAI | Caris Life Sciences Inc | 0.35% | $16.52 | $4.35B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 73 | +68.46% | $28 | 0.00% | 1.49 |
60 | NAMS | Newamsterdam Pharma Co Nv | 0.34% | $31.71 | $4.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +58.25% | $50 | 0.00% | 1.00 |
61 | TVTX | Travere Therapeutics Inc Ordinary Shares | 0.33% | $42.96 | $4.41B | Biotechnology | Healthcare | -44.12% | N/A | 61.73 | N/A | N/A | N/A | 76 | +26.02% | $54 | +24.56% | 1.30 |
62 | TWST | Twist Bioscience Corp | 0.32% | $70.15 | $3.99B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 75 | -8.14% | $64 | -6.10% | 2.04 |
63 | AMRX | N/A | 0.32% | $12.65 | $4.04B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 40.55 | 6.30 | N/A | N/A | N/A | 85 | +35.97% | $17 | +18.00% | 0.97 |
64 | CRNX | Crinetics Pharmaceuticals Inc | 0.31% | $32.61 | $3.87B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +13.39% | N/A |
65 | EWTX | Edgewise Therapeutics Inc | 0.29% | $37.25 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +18.58% | $44 | +7.36% | 1.37 |
66 | ACAD | Acadia Pharmaceuticals Inc | 0.29% | $20.89 | $3.63B | Biotechnology | Healthcare | N/A | 9.59 | 62.50 | 0.16 | N/A | N/A | 72 | +51.51% | $32 | -2.17% | 0.95 |
67 | ERAS | Erasca Inc | 0.29% | $13.48 | $3.88B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +50.59% | $20 | 0.00% | 1.30 |
68 | VCYT | Veracyte Inc | 0.28% | $47.80 | $3.55B | Diagnostics & Research | Healthcare | N/A | 40.15 | 28.01 | 0.25 | N/A | N/A | 70 | -0.84% | $47 | +7.11% | 1.41 |
69 | DNLI | Denali Therapeutics Inc | 0.25% | $19.35 | $3.21B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +75.35% | $34 | -21.40% | 1.56 |
70 | GPCR | Structure Therapeutics Inc Adr | 0.25% | $37.19 | $2.81B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +186.29% | $106 | 0.00% | 0.89 |
71 | BEAM | Beam Therapeutics Inc | 0.24% | $28.96 | $3.28B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +76.35% | $51 | -18.35% | 1.79 |
72 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.24% | $17.24 | $3B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +121.87% | $38 | -0.88% | 1.83 |
73 | TXG | N/A | 0.23% | $30.71 | $3.27B | Health Information Services | Healthcare | N/A | N/A | 500.00 | N/A | N/A | N/A | 60 | -17.84% | $25 | -29.23% | 1.98 |
74 | ALMS | Alumis Inc | 0.23% | $20.04 | $2.67B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +100.10% | $40 | 0.00% | 0.84 |
75 | ORKA | Oruka Therapeutics Inc | 0.23% | $55.23 | $2.91B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +157.41% | $142 | +15.52% | N/A |
76 | SUPN | Supernus Pharmaceuticals Inc | 0.22% | $44.07 | $2.71B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +42.57% | $63 | +8.17% | 0.51 |
77 | TNGX | Tango Therapeutics Inc | 0.22% | $21.50 | $2.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +48.37% | $32 | +14.39% | 1.35 |
78 | GRAL | Grail Inc | 0.22% | $59.90 | $2.94B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 62 | +11.62% | $67 | 0.00% | 2.23 |
79 | ARQT | N/A | 0.21% | $20.79 | $2.64B | Biotechnology | Healthcare | -58.89% | N/A | 119.05 | N/A | N/A | N/A | 78 | +66.52% | $35 | -4.91% | 1.28 |
80 | IRON | Disc Medicine Inc Ordinary Shares | 0.21% | $68 | $2.66B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +48.66% | $101 | -11.63% | 1.16 |
81 | TARS | N/A | 0.21% | $57.41 | $2.58B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +63.93% | $94 | +11.68% | 0.65 |
82 | IDYA | Ideaya Biosciences Inc | 0.21% | $27.87 | $2.57B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +85.47% | $52 | +6.44% | 1.11 |
83 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.20% | $15.70 | $2.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +54.46% | $24 | -13.31% | 1.84 |
84 | LEGN | Legend Biotech Corp Adr | 0.20% | $36.28 | $5.26B | Biotechnology | Healthcare | -13.49% | N/A | 181.82 | N/A | N/A | N/A | 80 | +52.67% | $55 | -1.81% | 0.54 |
85 | ELVN | Enliven Therapeutics Inc | 0.20% | $35.52 | $2.52B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +60.47% | $57 | +1.63% | 1.23 |
86 | VERA | Vera Therapeutics Inc Class A | 0.20% | $31.26 | $2.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +149.52% | $78 | +16.05% | 1.25 |
87 | KNSA | N/A | 0.20% | $46.92 | $3.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 57.45 | 44.05 | N/A | N/A | N/A | 78 | +35.34% | $64 | +28.66% | 0.58 |
88 | MLYS | Mineralys Therapeutics Inc | 0.19% | $28.85 | $2.47B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +68.11% | $49 | 0.00% | 0.78 |
89 | DFTX | N/A | 0.18% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
90 | KOD | Kodiak Sciences Inc | 0.18% | $33.22 | $2.18B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 75 | +88.68% | $63 | -15.75% | 1.73 |
91 | RARE | Ultragenyx Pharmaceutical Inc | 0.18% | $21.78 | $2.30B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +138.98% | $52 | -25.42% | 1.00 |
92 | ADPT | Adaptive Biotechnologies Corp | 0.18% | $15.14 | $2.21B | Diagnostics & Research | Healthcare | -22.53% | N/A | N/A | N/A | N/A | N/A | 78 | +33.03% | $20 | -15.72% | 1.70 |
93 | BCRX | Biocryst Pharmaceuticals Inc | 0.17% | $8.34 | $2.32B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 74.63 | N/A | N/A | N/A | 82 | +155.40% | $21 | -12.61% | 0.79 |
94 | NVCR | Novocure Ltd | 0.17% | $15.82 | $1.97B | Medical Devices | Healthcare | N/A | N/A | 909.09 | N/A | N/A | N/A | 71 | +66.18% | $26 | -40.10% | 1.43 |
95 | AUPH | Aurinia Pharmaceuticals Inc | 0.16% | $15.39 | $2.03B | Biotechnology | Healthcare | N/A | 9.25 | 19.88 | 0.02 | N/A | N/A | 64 | +10.46% | $17 | +3.75% | 0.72 |
96 | ADMA | Adma Biologics Inc | 0.16% | $7.60 | $1.84B | Biotechnology | Healthcare | N/A | 11.33 | 9.61 | N/A | N/A | N/A | 68 | +120.39% | $17 | +34.45% | 1.25 |
97 | OCUL | Ocular Therapeutix Inc | 0.15% | $8.31 | $1.87B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +212.88% | $26 | -10.44% | 1.35 |
98 | RAPP | Rapport Therapeutics Inc | 0.15% | $34.90 | $1.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +63.61% | $57 | 0.00% | 1.35 |
99 | SION | Sionna Therapeutics Inc | 0.15% | $36.48 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +41.45% | $52 | 0.00% | 0.93 |
100 | ZYME | Zymeworks Inc Registered Shs | 0.15% | $24.11 | $1.81B | Biotechnology | Healthcare | N/A | N/A | 24.57 | N/A | N/A | N/A | 78 | +66.53% | $40 | -5.09% | 0.84 |
IBBQ (INVESCO NASDAQ BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
93.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%